CNS Pharmaceuticals, Inc.

CNSP·NASDAQ·$5.22Share Price as of 11/2·$3MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/14/26 10-K/AFY 202504/30/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/14/25

Disclosures

8-KCurrent report10/02/26 8-KCurrent report07/02/26 8-KCurrent report05/04/26 8-KCurrent report03/11/26 8-KCurrent report03/02/26

Prospectuses and Registrations

424B3Prospectus05/26/26 S-3Shelf registration05/19/26 S-8Registration of securities for employees02/27/26 424B5Prospectus supplement09/19/25 424B4Prospectus05/14/25

Proxies

DEFA14AAdditional proxy materials08/25/26 DEF 14ADefinitive proxy08/21/26 DEFA14AAdditional proxy materials11/12/25 DEF 14ADefinitive proxy10/24/25 PRE 14APreliminary proxy10/10/25

Ownership

Form 3Initial insider ownership08/18/26 Form 4Insider transaction08/18/26 Form 4Insider transaction08/18/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction05/20/26

Other

EFFECTRequest for effectiveness05/26/26 CORRESPCorrespondence with the SEC05/22/26 UPLOADLetter from the SEC05/22/26 DD05/19/26 ARSAnnual report to shareholders10/28/25